Direct costs associated with the management of mucositis: A systematic review

Leticia Rodrigues-Oliveira,Luiz Paulo Kowalski, Marcos Santos,Gustavo Nader Marta, René-Jean Bensadoun,Manoela Domingues Martins,Marcio Ajudarte Lopes, Gilberto de Castro,William Nassib William,Aline Lauda Freitas Chaves,Cesar Augusto Migliorati,Ramzi G. Salloum,Carla Isabelly Rodrigues-Fernandes,Elisa Kauark-Fontes,Thaís Bianca Brandão,Alan Roger Santos-Silva, Ana Carolina Prado-Ribeiro

Oral Oncology（2021）

引用 0|浏览0

暂无评分

摘要

•Mucositis is an adverse event following cancer treatment.•Associated with increased use of resources, consultations and hospitalizations.•Costs range from 4,18 USD to values exceeding 299 214,14 USD per patient.•Mucositis exacerbates the economic burden on the patient, health-plan and health-system.•More prospective studies evaluating the costs associated with mucositis are needed.

查看译文

关键词

Mucositis,Health expenditures,Health care costs,Hospital charges,Hospital costs,Systematic review,Radiotherapy,Chemotherapy,Hematopoietic stem cell transplantation,Molecular targeted therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要